Fundraising Fox
Find your path to Hakan
Sign up to see every warm intro you have to Hakan
- Paths you didn't know you had: your email and LinkedIn already hold routes to Hakan. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Hakan Goker is Managing Director and head of the Biotechnology team at M Ventures, the strategic venture capital fund of Merck KGaA, where he oversees healthcare and life sciences investments. With 15 years of venture investing experience across Atlas Venture, Aescap Venture, and M Ventures since 2013, Goker has been involved in the formation and management of multiple companies including Artios Pharma, Orphazyme, f-Star, Bicycle Therapeutics, Nimbus Discovery, Storm Therapeutics, and Ribometrix. He is responsible for directing M Ventures' portfolio strategy from its Amsterdam headquarters, with additional offices in the US and Israel, focusing on early-stage investments and company creation in transformational biotechnology.
Contact· published on Hakan's own website
Investments
Board seats
Investor
ActitheraArtios PharmaAsceneuronForendo PharmaiOncturaMacrophage PharmaNouscomRaze TherapeuticsReproNovoRibometrixStorm TherapeuticsSynaffixTRIMTech Therapeutics
Sources: SEC Form D filings · curated public sources.
Colleagues at M Ventures
Network1
Investors connected to Hakan in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Hakan Goker?
- Hakan Goker is Managing Director and head of the Biotechnology team at M Ventures, the strategic venture capital fund of Merck KGaA, where he oversees healthcare and life sciences investments. With 15 years of venture investing experience across Atlas Venture, Aescap Venture, and M Ventures since 2013, Goker has been involved in the formation and management of multiple companies including Artios Pharma, Orphazyme, f-Star, Bicycle Therapeutics, Nimbus Discovery, Storm Therapeutics, and Ribometrix. He is responsible for directing M Ventures' portfolio strategy from its Amsterdam headquarters, with additional offices in the US and Israel, focusing on early-stage investments and company creation in transformational biotechnology.
- Where does Hakan Goker work?
- Hakan Goker is Managing Director at M Ventures.
- What boards does Hakan Goker sit on?
- Hakan Goker holds tracked board seats at Ribometrix.
- What companies has Hakan Goker invested in?
- Investments tracked here include Actithera, Artios Pharma, Asceneuron, Forendo Pharma, iOnctura, Macrophage Pharma, Nouscom, Raze Therapeutics, ReproNovo, Ribometrix, Storm Therapeutics, Synaffix, and 1 more.
About this profile. Compiled from public sources — M Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights